The outcome of COVID‐19 in patients with hematological malignancy

In this study, we aim to report the outcomes for COVID‐19 in patients with hematological malignancy in Turkey. Data from laboratory‐confirmed 188 897 COVID‐19 patients diagnosed between 11 March 2020 and 22 June 2020 included in the Republic of Turkey, Ministry of Health database were analyzed retro...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Med Virol
Главные авторы: Yigenoglu, Tugce N., Ata, Naim, Altuntas, Fevzi, Bascı, Semih, Dal, Mehmet Sinan, Korkmaz, Serdal, Namdaroglu, Sinem, Basturk, Abdulkadir, Hacıbekiroglu, Tuba, Dogu, Mehmet H., Berber, İlhami, Dal, Kursat, Erkurt, Mehmet A., Turgut, Burhan, Ulgu, Mustafa Mahir, Celik, Osman, Imrat, Ersan, Birinci, Suayip
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2020
Предметы:
Research Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7436524/
https://ncbi.nlm.nih.gov/pubmed/32776581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.26404
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы